Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 24, 2022 Filed Mar 28, 2022 18:42 UTC |
Carr Michael A.Director · President and CEO
|
GrantStock Option (Right-to-Buy) · Derivative | 490,000 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0001615594-22-000018 · primary_doc.xml · derivative · entry 3 Carr Michael A. · CIK 0001875512 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 490,000 Underlying: Common Stock · 490,000 shares Expires 2032-03-24 F3 · derivative.exercise_date: Option vests as to 25% on each of the first four anniversaries of the date of the grant. Read SEC document |
| March 24, 2022 Filed Mar 28, 2022 18:42 UTC |
Carr Michael A.Director · President and CEO
|
GrantCommon Stock | 163,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-22-000018 · primary_doc.xml · nonDerivative · entry 2 Carr Michael A. · CIK 0001875512 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 428,000 F2 · shares: The Restricted Stock Units reported on this Form 4 vest in full on January 1, 2023. Read SEC document |
| March 24, 2022 Filed Mar 28, 2022 18:42 UTC |
Carr Michael A.Director · President and CEO
|
GrantCommon Stock | 205,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-22-000018 · primary_doc.xml · nonDerivative · entry 1 Carr Michael A. · CIK 0001875512 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,000 F1 · shares: The Restricted Stock Units reported on this Form 4 vest as to 1/3 of the shares on each of the first three anniversaries of the date of the grant. Read SEC document |
| March 24, 2022 Filed Mar 28, 2022 19:02 UTC |
Koschak WilliamChief Financial Officer
|
GrantStock Option (Right-to-Buy) · Derivative | 250,000 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0001615594-22-000021 · primary_doc.xml · derivative · entry 3 Koschak William · CIK 0001763989 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2032-03-24 F3 · derivative.exercise_date: Option vests as to 25% on each of the first four anniversaries of the date of the grant. Read SEC document |
| March 24, 2022 Filed Mar 28, 2022 19:02 UTC |
Koschak WilliamChief Financial Officer
|
GrantCommon Stock | 119,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-22-000021 · primary_doc.xml · nonDerivative · entry 2 Koschak William · CIK 0001763989 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,095 F2 · shares: The Restricted Stock Units reported on this Form 4 vest in full on January 1, 2023. Read SEC document |
| March 24, 2022 Filed Mar 28, 2022 19:02 UTC |
Koschak WilliamChief Financial Officer
|
GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-22-000021 · primary_doc.xml · nonDerivative · entry 1 Koschak William · CIK 0001763989 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,395 F1 · shares: The Restricted Stock Units reported on this Form 4 vest as to 1/3 of the shares on each of the first three anniversaries of the date of the grant. Read SEC document |
| March 24, 2022 Filed Mar 28, 2022 18:56 UTC |
Frimerman Debra HGeneral Counsel and Secretary
|
GrantStock Option (Right-to-Buy) · Derivative | 250,000 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0001615594-22-000020 · primary_doc.xml · derivative · entry 3 Frimerman Debra H · CIK 0001353541 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2032-03-24 F3 · derivative.exercise_date: Option vests as to 25% on each of the first four anniversaries of the date of the grant. Read SEC document |
| March 24, 2022 Filed Mar 28, 2022 18:56 UTC |
Frimerman Debra HGeneral Counsel and Secretary
|
GrantCommon Stock | 100,450 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-22-000020 · primary_doc.xml · nonDerivative · entry 2 Frimerman Debra H · CIK 0001353541 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,948 F2 · shares: The Restricted Stock Units reported on this Form 4 vest in full on January 1, 2023. Read SEC document |
| March 24, 2022 Filed Mar 28, 2022 18:56 UTC |
Frimerman Debra HGeneral Counsel and Secretary
|
GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-22-000020 · primary_doc.xml · nonDerivative · entry 1 Frimerman Debra H · CIK 0001353541 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,498 F1 · shares: The Restricted Stock Units reported on this Form 4 vest as to 1/3 of the shares on each of the first three anniversaries of the date of the grant. Read SEC document |
| March 24, 2022 Filed Mar 28, 2022 22:50 UTC |
Frey TravisChief Technology Officer
|
GrantStock Option (Right-to-Buy) · Derivative | 250,000 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0001615594-22-000019 · primary_doc.xml · derivative · entry 3 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2032-03-24 F3 · derivative.exercise_date: Option vests as to 25% on each of the first four anniversaries of the date of the grant. Read SEC document |
| March 24, 2022 Filed Mar 28, 2022 22:50 UTC |
Frey TravisChief Technology Officer
|
GrantCommon Stock | 105,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-22-000019 · primary_doc.xml · nonDerivative · entry 2 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,877 F2 · shares: The Restricted Stock Units reported on this Form 4 vest in full on January 1, 2023. Read SEC document |
| March 24, 2022 Filed Mar 28, 2022 22:50 UTC |
Frey TravisChief Technology Officer
|
GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-22-000019 · primary_doc.xml · nonDerivative · entry 1 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,227 F1 · shares: The Restricted Stock Units reported on this Form 4 vest as to 1/3 of the shares on each of the first three anniversaries of the date of the grant. Read SEC document |
| March 21, 2022 Filed Mar 22, 2022 16:09 UTC |
Ribeill Yves JDirector
|
SaleCommon Stock | 20,000 | $1.06 | $21,238.00 |
DisclosureSEC source: 0001615594-22-000016 · primary_doc.xml · nonDerivative · entry 1 Ribeill Yves J · CIK 0001604049 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,225 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on September 21, 2021. F2 · price: The price reported in Column 4 is a weighted average. The shares were sold in multiple transactions at prices ranging from $1.04 to $1.14, inclusive. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 18:19 UTC |
Koschak WilliamChief Financial Officer
|
Tax withholdingCommon Stock | 2,605 | $1.05 | $2,739.94 |
DisclosureSEC source: 0001615594-22-000013 · primary_doc.xml · nonDerivative · entry 1 Koschak William · CIK 0001763989 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,395 F1 · shares: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on February 22, 2021. F2 · price: The price reported in Column 4 is a weighted average. The shares were sold in multiple transactions at prices ranging from $1.05 to $1.06, inclusive. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 18:23 UTC |
Frimerman Debra HGeneral Counsel and Secretary
|
Tax withholdingCommon Stock | 2,502 | $1.08 | $2,702.16 |
DisclosureSEC source: 0001615594-22-000014 · primary_doc.xml · nonDerivative · entry 1 Frimerman Debra H · CIK 0001353541 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,498 F1 · shares: Shares were sold to cover tax withholding obligations of reporting person in connection with the vesting of Restricted Stock Units. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 22:26 UTC |
Frey TravisChief Technology Officer
|
Tax withholdingCommon Stock | 2,173 | $1.08 | $2,346.84 |
DisclosureSEC source: 0001615594-22-000015 · primary_doc.xml · nonDerivative · entry 1 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,227 F1 · shares: Shares were sold to cover tax withholding obligations of reporting person in connection with the vesting of Restricted Stock Units. Read SEC document |
| August 30, 2021 Filed Aug 31, 2021 16:53 UTC |
Carr Michael A.Director · President and CEO
|
PurchaseCommon Stock | 10,000 | $3.98 | $39,776.00 |
DisclosureSEC source: 0001615594-21-000096 · primary_doc.xml · nonDerivative · entry 1 Carr Michael A. · CIK 0001875512 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 F1 · price: The price reported in Column 4 is a weighted average. The shares were purchased in multiple transactions at prices ranging from $3.9250 to $4.05, inclusive. Read SEC document |
| August 19, 2021 Filed Aug 23, 2021 16:31 UTC |
Koschak WilliamChief Financial Officer
|
PurchaseCommon Stock | 20,000 | $3.21 | $64,112.00 |
DisclosureSEC source: 0001615594-21-000095 · primary_doc.xml · nonDerivative · entry 1 Koschak William · CIK 0001763989 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,000 F1 · price: The price reported in Column 4 is a weighted average. The shares were purchased in multiple transactions at prices ranging from $3.18 to $4.1799, inclusive. Read SEC document |
| July 27, 2021 Filed Jul 28, 2021 17:18 UTC |
Carr Michael A.Director · President and CEO
|
GrantPerformance Stock Units · Derivative | 600,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-21-000078 · primary_doc.xml · derivative · entry 3 Carr Michael A. · CIK 0001875512 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600,000 Underlying: Common Stock · 600,000 shares Expires 2024-07-27 F3 · derivative.exercise_price: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of Calyxt common stock. The PSUs vest upon Calyxt's common stock achieving specified prices per share for all of the trading days in any 30 consecutive calendar day period within a three year performance period. F3 · derivative.exercise_date: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of Calyxt common stock. The PSUs vest upon Calyxt's common stock achieving specified prices per share for all of the trading days in any 30 consecutive calendar day period within a three year performance period. Read SEC document |
| July 27, 2021 Filed Jul 28, 2021 17:18 UTC |
Carr Michael A.Director · President and CEO
|
GrantStock Option (Right-to-Buy) · Derivative | 200,000 | $0.00 Strike: $3.65 | $0.00 |
DisclosureSEC source: 0001615594-21-000078 · primary_doc.xml · derivative · entry 2 Carr Michael A. · CIK 0001875512 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2031-07-27 F2 · derivative.exercise_date: The Option vests as to one-third (1/3) on each of the first three anniversaries of the date of the grant. Read SEC document |
| July 27, 2021 Filed Jul 28, 2021 17:18 UTC |
Carr Michael A.Director · President and CEO
|
GrantCommon Stock | 50,000 | $3.65 | $182,500.00 |
DisclosureSEC source: 0001615594-21-000078 · primary_doc.xml · nonDerivative · entry 1 Carr Michael A. · CIK 0001875512 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 F1 · shares: The Restricted Stock Units vest as to one-third (1/3) on each of the first three anniversaries of the date of the grant. Read SEC document |
| July 27, 2021 Filed Jul 28, 2021 17:23 UTC |
Ribeill Yves JDirector · Executive Chair
|
GrantCommon Stock | 50,429 | $3.65 | $184,065.85 |
DisclosureSEC source: 0001615594-21-000079 · primary_doc.xml · nonDerivative · entry 1 Ribeill Yves J · CIK 0001604049 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,225 F1 · shares: The Restricted Stock Units vest as to one-third (1/3) on the date of the grant; one-third (1/3) on the six-month anniversary of the date of the grant; and the remaining one-third (1/3) on the one-year anniversary of the date of the grant. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 16:59 UTC |
Ribeill Yves JDirector · Executive Chair
|
GrantCommon Stock | 12,048 | $4.07 | $49,035.36 |
DisclosureSEC source: 0001615594-21-000074 · primary_doc.xml · nonDerivative · entry 1 Ribeill Yves J · CIK 0001604049 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,796 F1 · shares: The Restricted Stock Units vest as to one-third (1/3) on the effective date of an employment agreement appointing a permanent Chief Executive Officer (the "CEO Start Date"); one-third (1/3) on the six-month anniversary of the CEO Start Date; and the remainder shall vest on the one-year anniversary of the CEO Start Date. Read SEC document |
| June 08, 2021 Filed Jun 10, 2021 20:53 UTC |
Reiter SarahChief Business Officer
|
GrantStock Option (Right-to-Buy) · Derivative | 16,573 | $0.00 Strike: $4.54 | $0.00 |
DisclosureSEC source: 0001615594-21-000072 · primary_doc.xml · derivative · entry 2 Reiter Sarah · CIK 0001734605 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,573 Underlying: Common Stock · 16,573 shares Expires 2031-06-08 F2 · derivative.exercise_date: Option vests as to 1/3 of the shares on each of the first three anniversaries of the date of the grant. Read SEC document |
| June 08, 2021 Filed Jun 10, 2021 20:53 UTC |
Reiter SarahChief Business Officer
|
GrantCommon Stock | 11,601 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-21-000072 · primary_doc.xml · nonDerivative · entry 1 Reiter Sarah · CIK 0001734605 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,101 F1 · shares: Restricted Stock Units vest as to 1/3 of the shares on each of the first three anniversaries of the date of the grant. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 16:58 UTC |
Ribeill Yves JDirector · Executive Chair
|
GrantCommon Stock | 11,967 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-21-000069 · primary_doc.xml · nonDerivative · entry 1 Ribeill Yves J · CIK 0001604049 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,748 F1 · shares: The Restricted Stock Units vest as to one-third (1/3) on the effective date of an employment agreement appointing a permanent Chief Executive Officer (the "CEO Start Date"); one-third (1/3) on the six-month anniversary of the CEO Start Date; and the remainder shall vest on the one-year anniversary of the CEO Start Date. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 21:47 UTC |
Nelson Kimberly K.Director
|
GrantStock Option (Right-to-Buy) · Derivative | 15,231 | $0.00 Strike: $4.22 | $0.00 |
DisclosureSEC source: 0001615594-21-000068 · primary_doc.xml · derivative · entry 2 Nelson Kimberly K. · CIK 0001489097 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,231 Underlying: Common Stock · 15,231 shares Expires 2031-05-27 F2 · derivative.exercise_date: Option vests in full on 5/27/2022. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 21:47 UTC |
Nelson Kimberly K.Director
|
GrantCommon Stock | 7,204 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-21-000068 · primary_doc.xml · nonDerivative · entry 1 Nelson Kimberly K. · CIK 0001489097 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,204 F1 · shares: The Restricted Stock Units vest in full on 5/27/2022. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 17:42 UTC |
Ribeill Yves JDirector · Executive Chair
|
GrantStock Option (Right-to-Buy) · Derivative | 10,291 | $0.00 Strike: $4.22 | $0.00 |
DisclosureSEC source: 0001615594-21-000067 · primary_doc.xml · derivative · entry 2 Ribeill Yves J · CIK 0001604049 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,291 Underlying: Common Stock · 10,291 shares Expires 2031-05-27 F2 · derivative.exercise_date: Option vests in full on 5/27/2022. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 17:42 UTC |
Ribeill Yves JDirector · Executive Chair
|
GrantCommon Stock | 18,730 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-21-000067 · primary_doc.xml · nonDerivative · entry 1 Ribeill Yves J · CIK 0001604049 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,781 F1 · shares: The Restricted Stock Units vest in full on 5/27/2022. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 17:33 UTC |
NEUGENT CHRISTOPHER JDirector
|
GrantStock Option (Right-to-Buy) · Derivative | 14,408 | $0.00 Strike: $4.22 | $0.00 |
DisclosureSEC source: 0001615594-21-000065 · primary_doc.xml · derivative · entry 3 NEUGENT CHRISTOPHER J · CIK 0001657549 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,408 Underlying: Common Stock · 14,408 shares Expires 2031-05-27 F3 · derivative.exercise_date: The option vests in full on 5/27/2022. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 17:33 UTC |
NEUGENT CHRISTOPHER JDirector
|
GrantCommon Stock | 7,204 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-21-000065 · primary_doc.xml · nonDerivative · entry 1 NEUGENT CHRISTOPHER J · CIK 0001657549 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,804 F1 · shares: The Restricted Stock Units vest in full on 5/27/2022. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 21:37 UTC |
Kozicz-Stankiewicz Anna EwaDirector
|
GrantStock Option (Right-to-Buy) · Derivative | 12,761 | $0.00 Strike: $4.22 | $0.00 |
DisclosureSEC source: 0001615594-21-000066 · primary_doc.xml · derivative · entry 2 Kozicz-Stankiewicz Anna Ewa · CIK 0001712090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,761 Underlying: Common Stock · 12,761 shares Expires 2031-05-27 F2 · derivative.exercise_date: Option vests in full on 5/27/2022. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 21:37 UTC |
Kozicz-Stankiewicz Anna EwaDirector
|
GrantCommon Stock | 7,204 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-21-000066 · primary_doc.xml · nonDerivative · entry 1 Kozicz-Stankiewicz Anna Ewa · CIK 0001712090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,089 F1 · shares: The Restricted Stock Units vest in full on 5/27/2022. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 21:27 UTC |
Jonathan FassbergDirector
|
GrantStock Option (Right-to-Buy) · Derivative | 10,291 | $0.00 Strike: $4.22 | $0.00 |
DisclosureSEC source: 0001615594-21-000064 · primary_doc.xml · derivative · entry 2 Jonathan Fassberg · CIK 0001750985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,291 Underlying: Common Stock · 10,291 shares Expires 2031-05-27 F2 · derivative.exercise_date: The option vests in full on 5/27/2022. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 21:27 UTC |
Jonathan FassbergDirector
|
GrantCommon Stock | 7,204 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-21-000064 · primary_doc.xml · nonDerivative · entry 1 Jonathan Fassberg · CIK 0001750985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,804 F1 · shares: The Restricted Stock Units vest in full on 5/27/2022. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 21:24 UTC |
Dumont PhilippeDirector
|
GrantStock Option (Right-to-Buy) · Derivative | 10,291 | $0.00 Strike: $4.22 | $0.00 |
DisclosureSEC source: 0001615594-21-000063 · primary_doc.xml · derivative · entry 2 Dumont Philippe · CIK 0001712186 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,291 Underlying: Common Stock · 10,291 shares Expires 2031-05-27 F2 · derivative.exercise_date: The option vests in full on 5/27/2022. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 21:24 UTC |
Dumont PhilippeDirector
|
GrantCommon Stock | 7,204 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-21-000063 · primary_doc.xml · nonDerivative · entry 1 Dumont Philippe · CIK 0001712186 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,614 F1 · shares: The Restricted Stock Units vest in full on 5/27/2022. Read SEC document |
| May 12, 2021 Filed May 13, 2021 17:58 UTC |
NEUGENT CHRISTOPHER JDirector
|
PurchaseCommon Stock | 15,000 | $3.95 | $59,290.50 |
DisclosureSEC source: 0001615594-21-000056 · primary_doc.xml · nonDerivative · entry 2 NEUGENT CHRISTOPHER J · CIK 0001657549 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 15,000 F1 · ownership.nature: By Christopher J. Neugent Revocable Trust of which the reporting person and his wife are trustees and the reporting person is the beneficiary. Read SEC document |
| May 03, 2021 Filed May 5, 2021 16:51 UTC |
Ribeill Yves JDirector · Executive Chair
|
GrantCommon Stock | 9,430 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-21-000048 · primary_doc.xml · nonDerivative · entry 1 Ribeill Yves J · CIK 0001604049 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,051 F1 · shares: The Restricted Stock Units vest as to one-third (1/3) on the effective date of an employment agreement appointing a permanent Chief Executive Officer (the "CEO Start Date"); one-third (1/3) on the six-month anniversary of the CEO Start Date; and the remainder shall vest on the one-year anniversary of the CEO Start Date. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 16:43 UTC |
Ribeill Yves JDirector
|
GrantCommon Stock | 16,591 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-21-000042 · primary_doc.xml · nonDerivative · entry 1 Ribeill Yves J · CIK 0001604049 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,621 F1 · shares: The Restricted Stock Units reported on this Form 4 vest as to 1/3 of the shares on the effective date of an employment agreement appointing a permanent Chief Executive Officer of the Issuer (the "CEO Start Date"); 1/3 on the six-month anniversary of the CEO Start Date; and 1/3 on the one-year anniversary of the CEO Start Date. Read SEC document |
| March 12, 2021 Filed Mar 18, 2021 16:49 UTC |
Koschak WilliamChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 18,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-21-000031 · primary_doc.xml · derivative · entry 3 Koschak William · CIK 0001763989 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Calyxt, Inc. common stock. F3 · derivative.exercise_date: The restricted stock units vest in full on March 12, 2022. F3 · derivative.expiration_date: The restricted stock units vest in full on March 12, 2022. Read SEC document |
| March 12, 2021 Filed Mar 18, 2021 16:49 UTC |
Koschak WilliamChief Financial Officer
|
GrantStock Option (Right-to-Buy) · Derivative | 26,000 | $0.00 Strike: $8.05 | $0.00 |
DisclosureSEC source: 0001615594-21-000031 · primary_doc.xml · derivative · entry 2 Koschak William · CIK 0001763989 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,000 Underlying: Common Stock · 26,000 shares Expires 2031-03-12 F1 · derivative.exercise_date: Options vest as to 1/3 of the shares on each of the first three anniversaries of the date of the grant. Read SEC document |
| March 12, 2021 Filed Mar 18, 2021 16:43 UTC |
Frimerman Debra HGeneral Counsel and Secretary
|
GrantRestricted Stock Units · Derivative | 19,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-21-000030 · primary_doc.xml · derivative · entry 3 Frimerman Debra H · CIK 0001353541 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,000 Underlying: Common Stock · 19,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Calyxt, Inc. common stock. F3 · derivative.exercise_date: The restricted stock units vest in full on March 12, 2022. F3 · derivative.expiration_date: The restricted stock units vest in full on March 12, 2022. Read SEC document |
| March 12, 2021 Filed Mar 18, 2021 16:43 UTC |
Frimerman Debra HGeneral Counsel and Secretary
|
GrantStock Option (Right-to-Buy) · Derivative | 27,000 | $0.00 Strike: $8.05 | $0.00 |
DisclosureSEC source: 0001615594-21-000030 · primary_doc.xml · derivative · entry 2 Frimerman Debra H · CIK 0001353541 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,000 Underlying: Common Stock · 27,000 shares Expires 2031-03-12 F1 · derivative.exercise_date: Option vests as to 1/3 of the shares on each of the first three anniversaries of the date of the grant. Read SEC document |
| March 12, 2021 Filed Mar 18, 2021 16:54 UTC |
NEUGENT CHRISTOPHER JDirector
|
GrantRestricted Stock Units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-21-000032 · primary_doc.xml · derivative · entry 2 NEUGENT CHRISTOPHER J · CIK 0001657549 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Calyxt, Inc. common stock. F2 · derivative.exercise_date: The restricted stock units vest in full on March 12, 2022. F2 · derivative.expiration_date: The restricted stock units vest in full on March 12, 2022. Read SEC document |
| March 12, 2021 Filed Mar 18, 2021 20:31 UTC |
Frey TravisChief Technology Officer
|
GrantRestricted Stock Units · Derivative | 16,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-21-000029 · primary_doc.xml · derivative · entry 3 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,500 Underlying: Common Stock · 16,500 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Calyxt, Inc. common stock. F3 · derivative.exercise_date: The restricted stock units vest in full on March 12, 2022. F3 · derivative.expiration_date: The restricted stock units vest in full on March 12, 2022. Read SEC document |
| March 12, 2021 Filed Mar 18, 2021 20:31 UTC |
Frey TravisChief Technology Officer
|
GrantStock Option (Right-to-Buy) · Derivative | 24,000 | $0.00 Strike: $8.05 | $0.00 |
DisclosureSEC source: 0001615594-21-000029 · primary_doc.xml · derivative · entry 2 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2031-03-12 F1 · derivative.exercise_date: Option vests as to 1/3 of the shares on each of the first three anniversaries of the date of the grant. Read SEC document |
| March 12, 2021 Filed Apr 2, 2021 16:52 UTC Amendment |
Koschak WilliamChief Financial Officer
|
GrantStock Option (Right-to-Buy) · Derivative | 26,000 | $0.00 Strike: $8.05 | $0.00 |
DisclosureSEC source: 0001615594-21-000044 · primary_doc.xml · derivative · entry 2 Koschak William · CIK 0001763989 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,000 Underlying: Common Stock · 26,000 shares Expires 2031-03-12 F2 · derivative.exercise_date: Option vests as to 1/3 of the shares on each of the first three anniversaries of the date of the grant. Read SEC document |
| March 12, 2021 Filed Apr 2, 2021 16:52 UTC Amendment |
Koschak WilliamChief Financial Officer
|
GrantCommon Stock | 18,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-21-000044 · primary_doc.xml · nonDerivative · entry 1 Koschak William · CIK 0001763989 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 F1 · shares: The Restricted Stock Units reported on this Form 4 vest as to 1/3 of the shares on each of the first three anniversaries of the date of the grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.